Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.
EU Commissioner Mariya Gabriel shares her ambitious policy plans on the coronavirus pandemic, especially in relation to research and innovation in Europe.
Fintan Grant, NHS Digital’s Programme Head for Medicines and Pharmacy charts the recent change in the speed of healthcare delivery in light of COVID-19 including the importance of digital solutions.
Dr Deborah Lee from Dr Fox Online Pharmacy discusses why we need to wear a face covering during the current COVID-19 pandemic, stating the evidence in this illuminating analysis.
Scientists at the University of Exeter found that tropical peatland conservation can impact how animal diseases, like the bat-based COVID-19, transfers to human beings.
Global financial exclusion rates are on the rise thanks to the COVID-19 crisis. Matt Adam, chief executive, We Are Digital, outlines five ways we can solve the world’s money troubles as we head back into lockdown.
Eight days after the Pfizer vaccine results (90% effective) brought collective hope to the world, the Moderna vaccine has proven to be 95% effective at fighting COVID-19.
Loneliness during lockdown is one of the most universal afflictions - when researchers studied young adults in the US, they found "alarming" levels of COVID-19 depression.
Alexander Zeitelhack, Associate Dean, Berlin School of Business and Innovation charts the digital transformation revolution during COVID-19 and why it took so long to get us to the this stage.
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
Gino Martini, RPS Chief Scientist and the Science and Research Team at the Royal Pharmaceutical Society reflect on the role of pharmacy during COVID-19 in delivering accessible, safe and effective care for all.
European Public Health Association Executive Director, Dineke Zeegers Paget examines COVID-19 as a societal issue, not just a pandemic and argues that solidarity here is needed the most.
